| 產(chǎn)品編號 | 圖片 | CAS No. | 名稱及描述 | 規(guī)格 | 價格 | 分子式 | 快速訂購 |
|---|---|---|---|---|---|---|---|
| GC39648-5mg |
|
2194903-42-7 |
H3B-120 - Glpbio |
0 | 需詢價 | C19H24N4O2S | |
| GC39647-100mg |
|
1055411-77-2 |
Dopamine D2 receptor antagonist-1 - Glpbio |
0 | 需詢價 | C14H17N3S | |
| GC39647-50mg |
|
1055411-77-2 |
Dopamine D2 receptor antagonist-1 - Glpbio |
0 | 需詢價 | C14H17N3S | |
| GC39647-10mg |
|
1055411-77-2 |
Dopamine D2 receptor antagonist-1 - Glpbio |
0 | 需詢價 | C14H17N3S | |
| GC39647-5mg |
|
1055411-77-2 |
Dopamine D2 receptor antagonist-1 - Glpbio |
0 | 需詢價 | C14H17N3S | |
| GC39646-100mg |
|
187739-60-2 |
Carboxyamidotriazole Orotate - Glpbio |
0 | 需詢價 | C22H16Cl3N7O6 | |
| GC39646-50mg |
|
187739-60-2 |
Carboxyamidotriazole Orotate - Glpbio |
0 | 需詢價 | C22H16Cl3N7O6 | |
| GC39646-10mg |
|
187739-60-2 |
Carboxyamidotriazole Orotate - Glpbio |
0 | 需詢價 | C22H16Cl3N7O6 | |
| GC39646-5mg |
|
187739-60-2 |
Carboxyamidotriazole Orotate - Glpbio |
0 | 需詢價 | C22H16Cl3N7O6 | |
| GC39645-100mg |
|
1613191-99-3 |
ATR inhibitor 2 - Glpbio |
0 | 需詢價 | C25H29F2N9O3 | |
| GC39645-50mg |
|
1613191-99-3 |
ATR inhibitor 2 - Glpbio |
0 | 需詢價 | C25H29F2N9O3 | |
| GC39645-10mg |
|
1613191-99-3 |
ATR inhibitor 2 - Glpbio |
0 | 需詢價 | C25H29F2N9O3 | |
| GC39645-5mg |
|
1613191-99-3 |
ATR inhibitor 2 - Glpbio |
0 | 需詢價 | C25H29F2N9O3 | |
| GC39644-50mg |
|
2127109-85-5 |
Tyk2-IN-9 - Glpbio |
0 | 需詢價 | C20H17N9 | |
| GC39644-10mg |
|
2127109-85-5 |
Tyk2-IN-9 - Glpbio |
0 | 需詢價 | C20H17N9 | |
| GC39644-5mg |
|
2127109-85-5 |
Tyk2-IN-9 - Glpbio |
0 | 需詢價 | C20H17N9 | |
| GC39643-50mg |
|
70962-66-2 |
Sparfosic acid trisodium - Glpbio |
0 | 需詢價 | C6H7NNa3O8P | |
| GC39643-10mg |
|
70962-66-2 |
Sparfosic acid trisodium - Glpbio |
0 | 需詢價 | C6H7NNa3O8P | |
| GC39643-5mg |
|
70962-66-2 |
Sparfosic acid trisodium - Glpbio |
0 | 需詢價 | C6H7NNa3O8P | |
| GC39642-50mg |
|
888958-26-7 |
SARS-CoV-IN-2 - Glpbio |
0 | 需詢價 | C24H18ClFeN3O | |
小泰
|
010-60710855
|